Haniva Technology


Haniva was awarded a US Patent In March, 2017 for the Combination Therapy of non-thermal plasma and any DNA damaging agent activated by hypoxia (Patent number 9,586,056). As of May, 2021, they also received patent approval for their combination therapy from the Australian government.

Industries

Employees

1-10

Links


Org chart

Shoshanna Zucker
President & CEO
Collapse
No reports!

Board & advisors



Offices